Warning for consumers of CBD and cannabis oils sold on the EU market

In Prague, in the framework of the program Patient Focus Certification (PFC), the world's first independent testing took place of a. the quality of cannabidiol available on the retail market (CBD, a non-psychotropic substance from cannabis), and b. the composition of so-called cannabis oils available in the European Union. Results have positively confirmed the need for independent certification of the quality of mass-produced products made from cannabis.